Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 00:44 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableUnknownINTERVENTIONAL

Labor Scale Versus WHO Partograph in the Management of Labor

ClinicalTrials.gov · NCT02486822 · Registry updated: 2016-05-11

Condition / research focus: Dystocia
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-07. Completion: 2016-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Amniotomy (procedure) — also listed as: Artificial rupture of membranes
Oxytocin (drug) — also listed as: augmentation of labor
Cesarean Section (procedure) — also listed as: CS

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Assiut Faculty of Medicine - Women Health Hospital
Asyut, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Fetal Copeptin After Oxytocin Challenge Test

ClinicalTrials.gov · NCT01962701 · Registry updated: 2016-05-10

Condition / research focus: Pregnancy
Sponsor: University of Zurich
Countries with listed sites: Switzerland
Registry dates and results: Start: 2013-01. Completion: 2014-06 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

University Hospital Zurich, Department of Obstetrics
Zurich, Canton of Zurich, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Timing of Umbilical Cord Occlusion in Premature Babies( <33 w). Delayed vs Early.

ClinicalTrials.gov · NCT02187874 · Registry updated: 2016-04-26

Condition / research focus: Delayed Umbilical Cord Clamping Benefits; Postpartum Haemorrhage; Intraventricular Haemorrhage
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Countries with listed sites: Spain
Registry dates and results: Start: 2014-07. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

delayed umbilical cord occlusion (procedure)
early umbilical cord occlusion (procedure)
Oxytocin (drug)

Where the study takes place — 1 listed sites

Hospital Universitari de la Vall d'Hebron
Barcelona, Barcelona, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT

ClinicalTrials.gov · NCT00790062 · Registry updated: 2016-04-08

Condition / research focus: Uterine Atony; Postpartum Hemorrhage
Sponsor: University of Alabama at Birmingham
Countries with listed sites: United States
Registry dates and results: Start: 2008-11. Completion: 2010-06 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

University of Alabama at Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT01608958 · Registry updated: 2016-03-28

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: Ecuador · Turkey (Türkiye) · Vietnam
Registry dates and results: Start: 2012-05. Completion: 2012-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Oxytocin (drug)

Where the study takes place — 3 listed sites

Hospital Gineco-Obstétrico Isidro Ayora
Quito, Ecuador
Site recruitment: Not reported
SB Etlik Zübeyde Hanım Kadın Hastalıkları Eğitim ve Araştırma Hastanesi
Ankara, Turkey (Türkiye)
Site recruitment: Not reported
Huong Vuong Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stepwise Labor Induction Following Failure of Prostaglandin Vaginal Insert for Labor Induction

ClinicalTrials.gov · NCT02684305 · Registry updated: 2016-03-24

Condition / research focus: Induction of Labor
Sponsor: Tel-Aviv Sourasky Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-04. Completion: 2018-04 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Administration of Propess (drug)
balloon (device)
Intravenous oxytocin infusion (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT01914419 · Registry updated: 2016-03-11

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-04. Completion: 2015-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 2 listed sites

Shatby Maternity Hospital, Alexandria University
Alexandria, Egypt
Site recruitment: Not reported
El Galaa Teaching Hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

The Effect of Coadministration of Oral Propranolol to Oxytocin on Induction of Labor

ClinicalTrials.gov · NCT02702674 · Registry updated: 2016-03-09

Condition / research focus: Poor; Labor
Sponsor: Ain Shams Maternity Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-12. Completion: 2016-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

propranolol (drug) — also listed as: indral
placebo (drug)
Oxytocin (drug) — also listed as: syntocinon

Where the study takes place — 1 listed sites

Ain Shams maternity hospital
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of Labor

ClinicalTrials.gov · NCT02680938 · Registry updated: 2016-03-02

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-01. Completion: 2016-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon
saline (drug) — also listed as: placebo

Where the study takes place — 1 listed sites

kareem Sami mostafa
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in Senegal

ClinicalTrials.gov · NCT01713153 · Registry updated: 2016-02-25

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: Senegal
Registry dates and results: Start: 2012-06. Completion: 2014-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec, Misoclear
UnijectTM (device)

Where the study takes place — 1 listed sites

Health huts in the district of Thiadiaye and Kolda
Thiadiay and Kolda, Thiadiaye and Kolda, Senegal
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oxytocin as Adjunctive Therapy for Schizophrenia

ClinicalTrials.gov · NCT01699997 · Registry updated: 2016-02-24

Condition / research focus: Schizophrenia
Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli
Countries with listed sites: Italy
Registry dates and results: Start: 2014-01. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug)

Where the study takes place — 7 listed sites

Statistical Unit, Institute of Biomathematics, University of Urbino
Urbino, Pesaro Urbino, Italy
Site recruitment: Not reported
IRCCS Fatebenefratelli
Brescia, Italy
Site recruitment: Not reported
Department of Mental Health
Desenzano, Italy
Site recruitment: Not reported
Institute of Neuroscience, National Research Council
Milan, Italy
Site recruitment: Not reported
Department of Mental Health
Padua, Italy
Site recruitment: Not reported
Psychiatric Clinic, University of Pisa
Pisa, Italy
Site recruitment: Not reported
Psychiatric Clinic, University of Udine
Udine, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin and Resting State fMRI

ClinicalTrials.gov · NCT02689596 · Registry updated: 2016-02-24

Condition / research focus: Healthy
Sponsor: University Hospital Heidelberg
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-10. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3WithdrawnINTERVENTIONAL

Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities

ClinicalTrials.gov · NCT01710566 · Registry updated: 2016-02-15

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: No country reported
Registry dates and results: Start: 2013-07. Completion: 2014-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Misoprost
Oxytocin (drug) — also listed as: Oxytocin in Uniject

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effect Of Intra-muscular Administration of Dexamethasone in Induction of Labour

ClinicalTrials.gov · NCT02508402 · Registry updated: 2016-02-01

Condition / research focus: Medical Induction of Labor Affecting Fetus
Sponsor: Kasr El Aini Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-09. Completion: 2016-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dexamethasone (drug) — also listed as: epidrone
Placebo (drug) — also listed as: Normal saline

Where the study takes place — 1 listed sites

Mohamed Abdel Aziz El Sharkawy
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Deciphering the Role of Oxytocin in Motivation: an fMRI Study

ClinicalTrials.gov · NCT01722071 · Registry updated: 2016-01-29

Condition / research focus: Focus of Study: Neural Correlates of Oxytocin Administration
Sponsor: Tiffany Love
Countries with listed sites: United States
Registry dates and results: Start: 2012-10. Completion: 2015-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo (drug)
Oxytocin (drug) — also listed as: Syntocinon®

Where the study takes place — 1 listed sites

University of Michigan
Ann Arbor, Michigan, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial

ClinicalTrials.gov · NCT02304055 · Registry updated: 2016-01-27

Condition / research focus: Obstetrics
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-05. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Not reported
Cairo University Hospitals
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

The Use of Thromboelastometry (ROTEM) to Evaluate the Changes in Coagulation With Two Different Doses of Oxytocin Following Cesarean Delivery

ClinicalTrials.gov · NCT02063568 · Registry updated: 2015-12-16

Condition / research focus: Coagulation Changes With Oxytocin
Sponsor: Duke University
Countries with listed sites: United States
Registry dates and results: Start: 2015-01. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 1 listed sites

Duke University Hospital
Durham, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Induction With Foley OR Misoprostol (INFORM) Study

ClinicalTrials.gov · NCT01801410 · Registry updated: 2015-12-14

Condition / research focus: Pre-eclampsia; Fetus or Newborn; Effects of Induction of Labor
Sponsor: University of Liverpool
Countries with listed sites: India
Registry dates and results: Start: 2013-12. Completion: 2015-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Foley Catheter (device) — also listed as: Cervical ripening balloon, balloon catheter
Misoprostol (drug) — also listed as: Cytotec

Where the study takes place — 2 listed sites

Daga Memorial Women's Hospital
Nagpur, Maharashtra, India
Site recruitment: Not reported
Government Medical College (GMC)
Nagpur, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Oxytocin on Stress in Marijuana Users

ClinicalTrials.gov · NCT01335789 · Registry updated: 2015-12-14

Condition / research focus: Marijuana Dependence
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2011-03. Completion: 2012-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Saline (drug)

Where the study takes place — 1 listed sites

Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus

ClinicalTrials.gov · NCT02508220 · Registry updated: 2015-12-02

Condition / research focus: Chronic Tinnitus
Sponsor: Berthold Langguth, MD, Ph.D.
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-07. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (drug) — also listed as: Oxytocin
Placebo (drug) — also listed as: distilled water

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 00:44 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableUnknownINTERVENTIONAL

Labor Scale Versus WHO Partograph in the Management of Labor

ClinicalTrials.gov · NCT02486822 · Registry updated: 2016-05-11

Condition / research focus: Dystocia
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-07. Completion: 2016-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Amniotomy (procedure) — also listed as: Artificial rupture of membranes
Oxytocin (drug) — also listed as: augmentation of labor
Cesarean Section (procedure) — also listed as: CS

Where the study takes place — 1 listed sites

Assiut Faculty of Medicine - Women Health Hospital
Asyut, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Fetal Copeptin After Oxytocin Challenge Test

ClinicalTrials.gov · NCT01962701 · Registry updated: 2016-05-10

Condition / research focus: Pregnancy
Sponsor: University of Zurich
Countries with listed sites: Switzerland
Registry dates and results: Start: 2013-01. Completion: 2014-06 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

University Hospital Zurich, Department of Obstetrics
Zurich, Canton of Zurich, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Timing of Umbilical Cord Occlusion in Premature Babies( <33 w). Delayed vs Early.

ClinicalTrials.gov · NCT02187874 · Registry updated: 2016-04-26

Condition / research focus: Delayed Umbilical Cord Clamping Benefits; Postpartum Haemorrhage; Intraventricular Haemorrhage
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Countries with listed sites: Spain
Registry dates and results: Start: 2014-07. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

delayed umbilical cord occlusion (procedure)
early umbilical cord occlusion (procedure)
Oxytocin (drug)

Where the study takes place — 1 listed sites

Hospital Universitari de la Vall d'Hebron
Barcelona, Barcelona, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT

ClinicalTrials.gov · NCT00790062 · Registry updated: 2016-04-08

Condition / research focus: Uterine Atony; Postpartum Hemorrhage
Sponsor: University of Alabama at Birmingham
Countries with listed sites: United States
Registry dates and results: Start: 2008-11. Completion: 2010-06 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

University of Alabama at Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT01608958 · Registry updated: 2016-03-28

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: Ecuador · Turkey (Türkiye) · Vietnam
Registry dates and results: Start: 2012-05. Completion: 2012-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Oxytocin (drug)

Where the study takes place — 3 listed sites

Hospital Gineco-Obstétrico Isidro Ayora
Quito, Ecuador
Site recruitment: Not reported
SB Etlik Zübeyde Hanım Kadın Hastalıkları Eğitim ve Araştırma Hastanesi
Ankara, Turkey (Türkiye)
Site recruitment: Not reported
Huong Vuong Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stepwise Labor Induction Following Failure of Prostaglandin Vaginal Insert for Labor Induction

ClinicalTrials.gov · NCT02684305 · Registry updated: 2016-03-24

Condition / research focus: Induction of Labor
Sponsor: Tel-Aviv Sourasky Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-04. Completion: 2018-04 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Administration of Propess (drug)
balloon (device)
Intravenous oxytocin infusion (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT01914419 · Registry updated: 2016-03-11

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-04. Completion: 2015-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 2 listed sites

Shatby Maternity Hospital, Alexandria University
Alexandria, Egypt
Site recruitment: Not reported
El Galaa Teaching Hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

The Effect of Coadministration of Oral Propranolol to Oxytocin on Induction of Labor

ClinicalTrials.gov · NCT02702674 · Registry updated: 2016-03-09

Condition / research focus: Poor; Labor
Sponsor: Ain Shams Maternity Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-12. Completion: 2016-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

propranolol (drug) — also listed as: indral
placebo (drug)
Oxytocin (drug) — also listed as: syntocinon

Where the study takes place — 1 listed sites

Ain Shams maternity hospital
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of Labor

ClinicalTrials.gov · NCT02680938 · Registry updated: 2016-03-02

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-01. Completion: 2016-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon
saline (drug) — also listed as: placebo

Where the study takes place — 1 listed sites

kareem Sami mostafa
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in Senegal

ClinicalTrials.gov · NCT01713153 · Registry updated: 2016-02-25

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: Senegal
Registry dates and results: Start: 2012-06. Completion: 2014-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec, Misoclear
UnijectTM (device)

Where the study takes place — 1 listed sites

Health huts in the district of Thiadiaye and Kolda
Thiadiay and Kolda, Thiadiaye and Kolda, Senegal
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oxytocin as Adjunctive Therapy for Schizophrenia

ClinicalTrials.gov · NCT01699997 · Registry updated: 2016-02-24

Condition / research focus: Schizophrenia
Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli
Countries with listed sites: Italy
Registry dates and results: Start: 2014-01. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug)

Where the study takes place — 7 listed sites

Statistical Unit, Institute of Biomathematics, University of Urbino
Urbino, Pesaro Urbino, Italy
Site recruitment: Not reported
IRCCS Fatebenefratelli
Brescia, Italy
Site recruitment: Not reported
Department of Mental Health
Desenzano, Italy
Site recruitment: Not reported
Institute of Neuroscience, National Research Council
Milan, Italy
Site recruitment: Not reported
Department of Mental Health
Padua, Italy
Site recruitment: Not reported
Psychiatric Clinic, University of Pisa
Pisa, Italy
Site recruitment: Not reported
Psychiatric Clinic, University of Udine
Udine, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin and Resting State fMRI

ClinicalTrials.gov · NCT02689596 · Registry updated: 2016-02-24

Condition / research focus: Healthy
Sponsor: University Hospital Heidelberg
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-10. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3WithdrawnINTERVENTIONAL

Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in Communities

ClinicalTrials.gov · NCT01710566 · Registry updated: 2016-02-15

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: No country reported
Registry dates and results: Start: 2013-07. Completion: 2014-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Misoprost
Oxytocin (drug) — also listed as: Oxytocin in Uniject

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effect Of Intra-muscular Administration of Dexamethasone in Induction of Labour

ClinicalTrials.gov · NCT02508402 · Registry updated: 2016-02-01

Condition / research focus: Medical Induction of Labor Affecting Fetus
Sponsor: Kasr El Aini Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-09. Completion: 2016-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dexamethasone (drug) — also listed as: epidrone
Placebo (drug) — also listed as: Normal saline

Where the study takes place — 1 listed sites

Mohamed Abdel Aziz El Sharkawy
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Deciphering the Role of Oxytocin in Motivation: an fMRI Study

ClinicalTrials.gov · NCT01722071 · Registry updated: 2016-01-29

Condition / research focus: Focus of Study: Neural Correlates of Oxytocin Administration
Sponsor: Tiffany Love
Countries with listed sites: United States
Registry dates and results: Start: 2012-10. Completion: 2015-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo (drug)
Oxytocin (drug) — also listed as: Syntocinon®

Where the study takes place — 1 listed sites

University of Michigan
Ann Arbor, Michigan, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial

ClinicalTrials.gov · NCT02304055 · Registry updated: 2016-01-27

Condition / research focus: Obstetrics
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-05. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Not reported
Cairo University Hospitals
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

The Use of Thromboelastometry (ROTEM) to Evaluate the Changes in Coagulation With Two Different Doses of Oxytocin Following Cesarean Delivery

ClinicalTrials.gov · NCT02063568 · Registry updated: 2015-12-16

Condition / research focus: Coagulation Changes With Oxytocin
Sponsor: Duke University
Countries with listed sites: United States
Registry dates and results: Start: 2015-01. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 1 listed sites

Duke University Hospital
Durham, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Induction With Foley OR Misoprostol (INFORM) Study

ClinicalTrials.gov · NCT01801410 · Registry updated: 2015-12-14

Condition / research focus: Pre-eclampsia; Fetus or Newborn; Effects of Induction of Labor
Sponsor: University of Liverpool
Countries with listed sites: India
Registry dates and results: Start: 2013-12. Completion: 2015-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Foley Catheter (device) — also listed as: Cervical ripening balloon, balloon catheter
Misoprostol (drug) — also listed as: Cytotec

Where the study takes place — 2 listed sites

Daga Memorial Women's Hospital
Nagpur, Maharashtra, India
Site recruitment: Not reported
Government Medical College (GMC)
Nagpur, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Oxytocin on Stress in Marijuana Users

ClinicalTrials.gov · NCT01335789 · Registry updated: 2015-12-14

Condition / research focus: Marijuana Dependence
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2011-03. Completion: 2012-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Saline (drug)

Where the study takes place — 1 listed sites

Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus

ClinicalTrials.gov · NCT02508220 · Registry updated: 2015-12-02

Condition / research focus: Chronic Tinnitus
Sponsor: Berthold Langguth, MD, Ph.D.
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-07. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon (drug) — also listed as: Oxytocin
Placebo (drug) — also listed as: distilled water

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →